Cc1ccc(Nc2ccc(Nc3ccc(C)cc3)c3c2C(=O)c2c(O)ccc(O)c2C3=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?